The government has approved Biological E's Corbevax as a precaution dose for those above 18 years fully vaccinated with either Covishield o...

"Corbevax will be considered as a precaution dose after completion of 6 months or 26 weeks from the date of administration of the second do...

The National Technical Advisory Group on Immunisation (NTAGI) which reviewed the data of Corbevax earlier had found significant antibody re...

The COVID-19 Working Group of the National Technical Advisory Group on Immunisation (NTAGI) made the recommendation in its 48th meeting hel...

The WHO website states that the rolling data submission has begun on June 10 and the decision date on EUL is yet to be confirmed. The compa...

The experts will review its data for its use as a standalone vaccine and will also weigh its benefits as a booster shot and take a decision...

"We will review the data of Corbevax in our next meeting slated to happen this month and evaluate if mix and match of vaccines can be allow...

India's drug regulator on Saturday granted approval to Hyderabad-based Biological E's Covid-19 vaccine Corbevax to be allowed as a booster ...

The vaccine can be administered after 6 months of administration of primary vaccination (two doses) of Covaxin or Covishield vaccines for r...

The Drugs Controller General Of India (DCGI) had already approved Corbevax, India's first indigenously developed RBD protein subunit vaccin...

Responding to a query on whether COVID-19 vaccination will be an annual affair, Director General of Indian Council for Medical Research Bal...

"Data shows that in people who have taken Covishield, the protein vaccine Covovax works better as a booster than another dose of Covishield...

The pandemic is not over. There is a need to ensure universal vaccination at home and abroad. India needs to move quickly on its domestic r...

Booster doses will become available in India from January 10. The prioritisation and sequence of administration would be based on completin...

The subject experts committee (SEC), a body under India's drug regulator, will meet on Monday to review the applications for granting appro...

This comes even as the government's advisory group on Covid-19 is awaiting data from the National Institute of Virology (NIV), Pune before ...

Currently, phase 2/3 clinical trials of the second indigenously developed Corbevax, an RBD protein sub-unit vaccine to be administered in a...